Respiratory Flashcards
Monitoring and follow-up - PE
- Resolution of symptoms vs worse?
* If progressively worsening SOB despite anticoagulation in 3 months - consider P-HTN (up to 5%) - low threshold for TTE and repeat CTPA/VQ - Monitor for medication side effects
- Bleeding
- Skin necrosis (warfarin)
- Osteoporosis (heparin)
- Thrombocytopaenia (Heparin)
- Device migration (filters)
- Investigate for the cause if unprovoked - malignancy, thrombophilia)
- Review duration:
- 3-12 months for 1st episode - thereafter, decision is individualised
- Unprovoked proximal DVT/PE, active cancer, APS - indefinite
- Recurrent unprovoked - indefinite
- Provoked / transient risk factor - 3-12 months
Names of LABA medications (4)
All -terols
Salme-terol (Serevent): 50mcg
Eformo-terol (Oxis / Foradile): 6-12mcg
Indaca-terol (onbrez): 150-300mcg
Vilan-terol: 25mcg.
Names of LAMA medications (4)
Tiotrop-ium (Spiriva): 2.5-18mcg
Glycopyrron-ium (Seebri): 50mcg
Aclidin-ium (Bretaris): 322mcg
Umeclidin-ium (Incruse Ellipta): 62.5mcg
Names of ICS medications (4)?
Fluticasone (Flixotide): 50-125-250mcg
Budesonide (Pulmicort): 100-200-400mcg
Beclometasone (QVAR): 50-100mcg
Ciclesonide (Alvesco): 80-160mcg
ICS/LABA combinations? (5)
Symbicort (Budesonide, formoterol): 100/6, 200/6, 400/12 - know this!
Seretide (Fluticasone/Salmeterol: MDI or Accuhaler): 50/25-100/50-250/50-500/50mcgs.
Breo-Ellipta (Fluticasone, Vilanterol): 100/25-200/25mcgs.
Flutiform (Fluticasone, formoterol): 50/5-250/10mcgs.
DuoResp Spiromax (Budesonide, Formoterol): 200/6-400/12 mcgs.
LABA + LAMA combinations? (4)
Note - LABA + LAMA combi are single dose only, so must increase the puff (rather than changing inhaler itself)
Spiolto Respimat (tiotropium/olodaterol) 2.5/2.5mcg.
Ultibro-Breezhaler (indacaterol/glycopyrronium) 110/50mcg.
Anoro Ellipta (umeclidinium / vilanterol) 62.5/25mcg.
Brimica Genuair (Aclidinium/Formoterol) 340/12mcg.
ICS/LAMA/LABA formulation ? (1)
Trelegy Ellipta.
Fluticasone-umeclidinium-vilanterol
100/62.5/25
